Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice

Down syndrome (DS), characterized by trisomy of human chromosome 21, is associated with a variety of endocrine disorders as well as profound skeletal abnormalities. The low bone mass phenotype in DS is defined by low bone turnover due to decreased osteoclast and osteoblast activity, decreasing the u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JBMR Plus
Hauptverfasser: Williams, Diarra K, Parham, Sean G, Schryver, Eric, Akel, Nisreen S, Shelton, R Shane, Webber, Jessica, Swain, Francis L, Schmidt, Jami, Suva, Larry J, Gaddy, Dana
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2017
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6124205/
https://ncbi.nlm.nih.gov/pubmed/30283889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10025
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge